BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17976707)

  • 41. Inhibition of human leukemia xenograft in nude mice by adenovirus-mediated tissue inhibitor of metalloproteinase-3.
    Yu XF; Yang C; Liang LH; Liu B; Zhou B; Li B; Han ZC
    Leukemia; 2006 Jan; 20(1):1-8. PubMed ID: 16281069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bladder cancer therapy using combined proliferating cell nuclear antigen antisense oligonucleotides and recombinant adenovirus p53.
    Zhu Z; Xing S; Lin C; Zhang X; Fu M; Liang X; Zeng F; Lu G; Wu M
    Chin Med J (Engl); 2003 Dec; 116(12):1860-3. PubMed ID: 14687474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Recombinant adenovirus vectors carrying antisense matrix metalloproteinase-2 inhibits hepatocellular carcinoma growth in vivo].
    Zhang MM; Yan LN; Li DH; Liu JW; Gou XH; Han L; Su Z; Zhao LY; Hu HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):525-9. PubMed ID: 16909593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
    Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
    Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
    Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A
    J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
    Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
    Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Inhibition of adenovirus-mediated gene transfer of antisense matrix metalloproteinase-2 on hepatocellular carcinoma growth in vivo].
    Zhang MM; Yan LN; Li DH; Gou XH; Liu JW; Su Z; Han L; Zhao LY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):671-4. PubMed ID: 16174456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma.
    Araki K; Ahmad SM; Li G; Bray DA; Saito K; Wang D; Wirtz U; Sreedharan S; O'Malley BW; Li D
    Clin Cancer Res; 2008 Jun; 14(11):3514-9. PubMed ID: 18519784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil.
    Chu L; Gu J; Sun L; Qian Q; Qian C; Liu X
    Gene Ther; 2008 Apr; 15(7):484-94. PubMed ID: 18239605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IPP5, a novel inhibitor of protein phosphatase 1, suppresses tumor growth and progression of cervical carcinoma cells by inducing G2/M arrest.
    Zeng Q; Huang Y; Zeng L; Huang Y; Cai D; Zhang H
    Cancer Genet; 2012 Sep; 205(9):442-52. PubMed ID: 22939397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
    Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
    Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Combination of adenovirus p16(INK4A) gene therapy and ionizing radiation for laryngeal squamous cell carcinoma].
    Fu YJ; Liu SX; Xian JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):209-11. PubMed ID: 15071918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
    Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
    Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
    Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
    J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TIMP-3 gene transfection suppresses invasive and metastatic capacity of human hepatocarcinoma cell line HCC-7721.
    Zhang H; Wang YS; Han G; Shi Y
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):487-91. PubMed ID: 17897911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The animal research of recombinant adenovirus controlled by human telomerase reverse transcriptase promoter in the treatment of human prostate cancer].
    Zhang Y; Qi JC; Lian WF; Cai WQ; Li W; Liu KL
    Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(18):1252-5. PubMed ID: 17147886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.